Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Infection and Public Health|January 26, 2023
Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markersAnita Pirabe, Waltraud C Schrottmaier, Stefan Heber, et al.
Infection|September 9, 2022
Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohortMario Karolyi, Andreas Gruebl, Sara Omid, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2025
The overarching prognostic role of tumor progression prior to cytoreductive hepatectomy in NETLMVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2026
Perioperative and oncologic outcomes of vascular resection after neoadjuvant therapy in intrahepatic cholangiocarcinomaYawen Dong, David Pereyra, Zhihao Li, et al.
Frontiers in Cardiovascular Medicine|December 3, 2021
Platelet Phenotype Analysis of COVID-19 Patients Reveals Progressive Changes in the Activation of Integrin αIIbβ3, F13A1, the SARS-CoV-2 Target EIF4A1 and Annexin A5Huriye Ercan, Waltraud Cornelia Schrottmaier, Anita Pirabe, et al.
JHEP Reports : Innovation in Hepatology|March 24, 2025
Soluble TREM2 reflects liver fibrosis status and predicts postoperative liver dysfunction after liver surgeryJonas Santol, Dragana Rajcic, Gregor Ortmayr, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 3, 2025
Preoperative von Willebrand factor is an independent predictive biomarker for post-hepatectomy liver failure-A multivariable model with APRI+ALBIYawen Dong, Lindsey A Gregory, Vanja Podrascanin, et al.
Annals of Surgical Oncology|December 19, 2025
The Paradox of Grade 2 Pancreatic Neuroendocrine Tumors: G2a/G2b Subdivision in Patients With and Without Liver Metastases: A Retrospective Single-Center AnalysisVanja Podrascanin, Markus Ammann, Hallbera Gudmundsdottir, et al.
European Journal of Cancer (Oxford, England : 1990)|June 17, 2026
Real-world outcomes of adjuvant therapy after curative-intent resection for biliary tract cancerYawen Dong, David Pereyra, Vanja Podrascanin, et al.
Pageof 6